Capstone Investment Advisors’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$819K Sell
31,832
-6,464
-17% -$150K ﹤0.01% 1024
2026
Q1
$788K Buy
38,296
+12,113
+46% +$273K ﹤0.01% 946
2025
Q4
$621K Buy
26,183
+1,338
+5% +$32.6K ﹤0.01% 1064
2025
Q3
$619K Sell
24,845
-2,874
-10% -$61.9K ﹤0.01% 1260
2025
Q2
$638K Buy
+27,719
New +$642K ﹤0.01% 1034
2024
Q2
Sell
-51,454
Closed -$1.01M 2383
2024
Q1
$1.01M Buy
51,454
+12,575
+32% +$266K ﹤0.01% 1151
2023
Q4
$895K Buy
38,879
+13,525
+53% +$303K ﹤0.01% 1095
2023
Q3
$583K Buy
+25,354
New +$645K ﹤0.01% 1238

Other funds holding PRVA

Capstone Investment Advisors's PRVA Position: Q2 2026 in Review

Capstone Investment Advisors reduced its Privia Health (PRVA) stake by 17% in Q2 2026, selling an estimated $150K and leaving 31,832 shares worth $819K. The position accounts for ﹤0.01% of the portfolio, ranked #1024.

Capstone Investment Advisors first reported a position in PRVA in Q3 2023 and has held it in 8 quarters since. The position peaked at $1.01M in Q1 2024. 301 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Capstone Investment Advisors held 31,832 shares of Privia Health worth $819K as of Q2 2026.
  • Capstone Investment Advisors sold 6,464 Privia Health shares in Q2 2026, an estimated $150K.
  • Privia Health made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q2 2026, its #1024 holding.
  • Capstone Investment Advisors first reported a position in Privia Health in Q3 2023 and has held it in 8 quarters since.
  • Capstone Investment Advisors's Privia Health position peaked at $1.01M in Q1 2024.
  • 301 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.